HomeBUSINESS
BUSINESS

AstraZeneca’s Japan Crestor Sales Dive 71%
(Aug.3.2018)

AstraZeneca saw its Japan sales of the cholesterol fighter Crestor (rosuvastatin) in January-June plummet 71% year on year (72% on a constant exchange rate basis), dragged down by generic debuts in the second half of 2017 ...
(LOG IN FOR FULL STORY)